Vickie L. Capps, Director at Silverback Therapeutics, Inc. (SBTX), bought 9,523 shares at $21.00 ($200K) on 2020-12-08, disclosed to the SEC on 2020-12-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| NUVA | BUY | 2020-11-10 | $96K | — | Filing → |
| AMED | BUY | 2020-02-26 | $187K | — | Filing → |
| CNXR | BUY | 2016-06-14 | $24K | — | Filing → |